Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald A Lubet

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Seminars in Oncology|September 7, 2010
The use of animal models for cancer chemoprevention drug developmentVernon E Steele, Ronald A Lubet
Neoplasia (New York, N.Y.)|March 28, 2003
Differential gene expression in chemically induced mouse lung adenomasRuisheng Yao, Yian Wang, Ronald A Lubet, et al.
Oncogene|August 13, 2002
Differentially expressed genes associated with mouse lung tumor progressionRuisheng Yao, Yian Wang, Ronald A Lubet, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 23, 2011
Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemopreventionSusan M Fischer, Ernest T Hawk, Ronald A Lubet
Frontiers in Cell and Developmental Biology|May 11, 2023
Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitationsKonstantin H Dragnev, Christo P C Dragnev, Ronald A Lubet
Cancer Research|August 9, 2003
Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J miceYian Wang, Zhongqiu Zhang, Elizabeth Kastens, et al.
Molecular Carcinogenesis|August 29, 2014
Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemopreventionQi Zhang, Jing Pan, Ronald A Lubet, et al.
Neoplasia (New York, N.Y.)|December 16, 2005
Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J miceYing Yan, Yian Wang, Qing Tan, et al.
Chemico-Biological Interactions|August 22, 2009
Induced expression of drug metabolizing enzymes by preventive agents: role of the antioxidant response elementRonald A Lubet, Ruisheng Yao, Clinton J Grubbs, et al.
The Journal of Urology|February 23, 2010
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacyRonald A Lubet, Vernon E Steele, M Margaret Juliana, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Seminars in Oncology|September 7, 2010
The use of animal models for cancer chemoprevention drug developmentVernon E Steele, Ronald A Lubet
Neoplasia (New York, N.Y.)|March 28, 2003
Differential gene expression in chemically induced mouse lung adenomasRuisheng Yao, Yian Wang, Ronald A Lubet, et al.
Oncogene|August 13, 2002
Differentially expressed genes associated with mouse lung tumor progressionRuisheng Yao, Yian Wang, Ronald A Lubet, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 23, 2011
Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemopreventionSusan M Fischer, Ernest T Hawk, Ronald A Lubet
Frontiers in Cell and Developmental Biology|May 11, 2023
Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitationsKonstantin H Dragnev, Christo P C Dragnev, Ronald A Lubet
Cancer Research|August 9, 2003
Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J miceYian Wang, Zhongqiu Zhang, Elizabeth Kastens, et al.
Molecular Carcinogenesis|August 29, 2014
Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemopreventionQi Zhang, Jing Pan, Ronald A Lubet, et al.
Neoplasia (New York, N.Y.)|December 16, 2005
Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J miceYing Yan, Yian Wang, Qing Tan, et al.
Chemico-Biological Interactions|August 22, 2009
Induced expression of drug metabolizing enzymes by preventive agents: role of the antioxidant response elementRonald A Lubet, Ruisheng Yao, Clinton J Grubbs, et al.
The Journal of Urology|February 23, 2010
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacyRonald A Lubet, Vernon E Steele, M Margaret Juliana, et al.
Pageof 16